Teva Pharmaceutical Industries | TEVA - Ebitda

Stock Price
10,090.00
Daily Change
-220.00 -2.13%
Monthly
6.78%
Yearly
66.67%
Q2 Forecast
9,793.35

Teva Pharmaceutical Industries reported $1.06B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Aspen Pharmacare ZAR 6.06B 867M Jun/2024
Cipla INR 12.55B 6.4B Dec/2025
Dr.Reddys Laboratories INR 6.46B 14.43B Mar/2026
Guangzhou Baiy CNY 2.31B 2.71B Mar/2026
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Kalbe Farma IDR 1.3T 18.7B Jun/2025
Richter Gedeon HUF 84.16B 8.44B Dec/2024
Sh Fosun Pharma CNY 1.57B 128.23M Dec/2025
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026